FDA approves Dexcom SHARE™, the first remote mobile communications device used for Continuous Glucose Monitoring (CGM)
Dexcom SHARE, an accessory to the Dexcom G4® PLATINUM Continuous Glucose Monitoring System, uses a secure wireless connection to transmit the glucose levels of a person with diabetes to the smartphones of up to five designated recipients, or “followers.” These followers can remotely monitor a patient’s glucose information and receive alert notifications from almost anywhere via their Apple® iPhone® or iPod® touch. With Dexcom SHARE, parents and personal caregivers can monitor a child’s or loved one’s glucose data from a remote location, giving them peace of mind and reassurance when they are apart.
Dexcom Announces Data Integration Relationship with Asante Solutions, Makers of the Snap™ Insulin Pump
Asante Solutions, Inc., manufacturer of the Asante Snap Insulin Pump, and Dexcom announced today their intention to enable the Dexcom mobile app platform, which is currently under development, to integrate and display insulin data from the Asante Snap Insulin Pump.
Insulet Corporation and Dexcom announced today their intention to enable DexCom's mobile App platform, which is currently under development, to integrate data from Insulet's OmniPod System.
The first and only real-time professional CGM, the Dexcom G4 PLATINUM Professional Continuous Glucose Monitoring System (CGM) Receives FDA Approval
The first and only real-time professional CGM, the Dexcom G4® PLATINUM Professional Continuous Glucose Monitoring System (CGM) Receives FDA Approval. Trusted patient CGM system now available in professional version enabling clinicians to gain valuable insight into their patients’ glycemic profiles leading to improved glucose control.
Dexcom was honored by the publication ‘Fast Company’ in their annual ’50 Most Innovative Companies’ feature.
Tandem Diabetes Care and Dexcom Expand Development and Commercialization Agreement to Include Recently Approved G4™ PLATINUM CGM Sensor
For the second year in a row, Dexcom has been identified by Deloitte as one of the 500 fastest growing technologies in the US.
New Device for Diabetes Management is Most-Advanced CGM Available with up to 30% Improvement in Hypoglycemic Accuracy
Terrance Gregg talks with the Wall Street Reporter about some of the latest developments at Dexcom.
Dexcom, Inc. announced that it has received CE Mark (Conformité Européene) approval for its fourth generation continuous glucose monitoring system, the Dexcom G4® system, enabling commercialization of the Dexcom G4 system in the European Union and the countries in Asia and Latin America that recognize the CE Mark.